Quality Control of Chinese Medicines

Shao-ping Li, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Macau, China (spli@um.edu.mo)

Chinese medicines (CM) have been attracting interest and acceptance in many countries. An estimated 1.5 billion peoplenow use these preparations worldwide. This may be primarily because of the general belief that herbal drugs are without any side effect besides being cheap and effective. However, as more people are using CM products, there are increased reports on their adverse reactions. Therefore, quality control is crucial for ensuring the safety and efficacy of CM. However, different from western medicine, CM are usually used as whole plant and/or combination of several herbs, which contains more than tens to hundreds or even thousands of components. In addition, CM are usually considered that multiple constituents are responsible for the therapeutic effects. Especially, effective components in most CM are unknown, which greatly increases the difficulties of quality control. Therefore, a rational and effective quality control method for CM is helpful to improve CM. In this presentation, the key points for quality control of CM were discussed based on our research and experience.

---

Abstract Reference & Short Personal Biography of Presenting Author

Biography

Dr. Shao-ping Li, is a Distinguished Professor on Quality Control of Chinese Medicines and Deputy Director of the State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, and Editor of Journal of Pharmaceutical and Biomedical Analysis. His research is focused on quality control and active components of Chinese medicines. As an Editor-/Associate Editor- in-Chief, he has published 4 books in USA or China. He is also the author of over 300 peer refereed journal papers and book chapters, and holder of more than 10 China and US patents.

Dr. Li is also an advisor of American Herbal Pharmacopoeia and a member of Chinese Pharmacopoeia Commission, as well as an Associate Editor of Chinese Medicine, and member of Editorial Boards of Journal of Function Foods, Journal of Food and Drug Analysis, American Journal of Chinese Medicine, International Journal of Analytical Chemistry, Molecules, Acta Pharmaceutica Sinica A/B, Journal of Pharmaceutical Analysis, Chinese Pharmaceutical Journal, Chinese Journal of Pharmaceutical Analysis, and China Journal of Chinese Materia Medica, etc. He is an Associate Chairman, the Pharmaceutical Analysis Committee of Chinese Pharmaceutical Association, the Committee of Natural Medicinal Resources /China Society of Natural Resources, the Quality and Safety Evaluation Committee, and Medicinal Mushroom Committee of China Association of Chinese Materia Medica, the Committee of Analytical Science of Chinese Medicines of Chinese Society of Chinese Medicine, etc.

References

[1] Zhao, J., Ma, S. C., Li, S. P.  J. Pharm. Biomed. Anal. 2018, 147, 473-478.

[2] Li, S. P., Zhao, J., Yang, B. (2011). .  J. Pharm. Biomed. Anal. 2018, 55, 802-809.